Hydroxychloroquine-induced hyperpigmentation of the skin and bull’s-eye maculopathy in rheumatic patients: a case report and literature review

Hydroxychloroquine-induced hyperpigmentation of the skin and bull’s-eye maculopathy in rheumatic patients: a case report and literature review

Hydroxychloroquine (HCQ) is used as a traditional disease-modifying antirheumatic drugs (DMARDs), for the treatment of autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, it can cause serious adverse reactions, including hyperpigmentation of the ski...

Full description

Bibliographic Details
Main Authors: Ji-peng Peng, Xiao-yu Yang, Feng Luo, Xue-mei Yuan, Hong Xiong, Wu-kai Ma, Xue-ming Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
hydroxychloroquine
adverse drug reaction
hyperpigmentation of the skin
bull’s-eye maculopathy
literature review
autoimmune disease
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1383343/full

Similar Items

Similar Items